Your browser doesn't support javascript.
loading
A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid Tumors.
Tolcher, Anthony W; Bendell, Johanna C; Papadopoulos, Kyriakos P; Burris, Howard A; Patnaik, Amita; Fairbrother, Wayne J; Wong, Harvey; Budha, Nageshwar; Darbonne, Walter C; Peale, Franklin; Mamounas, Michael; Royer-Joo, Stephanie; Yu, Ron; Portera, Chia C; Infante, Jeffrey R.
Afiliação
  • Tolcher AW; South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, Texas. atolcher@start.stoh.com.
  • Bendell JC; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Papadopoulos KP; South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, Texas.
  • Burris HA; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Patnaik A; South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, Texas.
  • Fairbrother WJ; Genentech Inc., South San Francisco, California.
  • Wong H; Genentech Inc., South San Francisco, California.
  • Budha N; Genentech Inc., South San Francisco, California.
  • Darbonne WC; Genentech Inc., South San Francisco, California.
  • Peale F; Genentech Inc., South San Francisco, California.
  • Mamounas M; Genentech Inc., South San Francisco, California.
  • Royer-Joo S; Genentech Inc., South San Francisco, California.
  • Yu R; Genentech Inc., South San Francisco, California.
  • Portera CC; Genentech Inc., South San Francisco, California.
  • Infante JR; Sarah Cannon Research Institute, Nashville, Tennessee.
Clin Cancer Res ; 22(18): 4567-73, 2016 Sep 15.
Article em En | MEDLINE | ID: mdl-27076626

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Inibidoras de Apoptose / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Inibidoras de Apoptose / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article